A Highly Sensitive Nonextraction-Assisted HPLC Method with Fluorescence Detection for Quantification of Duvelisib in Plasma Samples and its Application to Pharmacokinetic Study in Rats

BACKGROUND: Duvelisib (DUV) is a new oral phosphoinositide-3-kinase (PI3K)-δ and PI3K-γ inhibitor. It has been recently granted an accelerated approval for treatment of adult patients with relapsed or refractory chronic lymphocytic leukemia (CLL) and small lymphocytic lymphoma (SLL). It is also effe...

Descripción completa

Detalles Bibliográficos
Autores principales: Sayed, Ahmed Y, Khalil, Nasr Y, Almomen, Aliyah, Alzoman, Nourah Z, Almehizia, Abdulrahman A, Darwish, Ibrahim A
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2021
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8232391/
https://www.ncbi.nlm.nih.gov/pubmed/34188446
http://dx.doi.org/10.2147/DDDT.S318714

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8232391/
https://www.ncbi.nlm.nih.gov/pubmed/34188446
http://dx.doi.org/10.2147/DDDT.S318714

Ejemplares similares